VentureLabs Portfolio

Current Portfolio

Description	Status	Initial Date
Developing unprecedented intracellular biotherapeutics.	Private	2011	View Profile
Commercializing a new class of RNA-based drugs.	Private	2010	View Profile
Transforming global nutrition.	Private	2010	View Profile
Commercializing chemical catalysts for upgrading waste biomass to fuels, chemicals, and materials.	Private	2010	View Profile
Developing powerful synthetic biology tools for engineering biotherapeutics.	Private	2009	View Profile
Developing anti-metastatic drugs as a new category of cancer therapeutics.	Private	2008	View Profile
Engineering and developing innovative protein-based therapeutics.	Private	2008	View Profile
Pioneering the production of Liquid Fuel from the Sun™.	Private	2007	View Profile
Optimizing the interface of diagnostic medicine and the healthcare consumer by simplifying blood sampling and testing.	Private	2007	View Profile
Developing next-generation medical diagnostic products.	Private	2006	View Profile
Developing patent-pending UltraClean™ fuels and sustainable chemicals made with the power of synthetic biology.	Private	2005	View Profile
Employing a novel synthesis method to produce unprecedented macrocyle diversity resulting in novel drugs.	Private	2004	View Profile
Innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests.	Public	2003	View Profile
Analyzes molecular patient data, accelerates the development process and clarifies decisions on therapeutics and diagnostics	Private	2001	View Profile
Pioneering evolutionary algorithms for marketing content optimization.	Private	2000	View Profile
Novel diagnostics to improve patient outcomes and contain healthcare costs.	Public	2000	View Profile

Flagship Ventures

VentureLabs Portfolio